BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 7937865)

  • 1. A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.
    Moriai T; Kobrin MS; Hope C; Speck L; Korc M
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10217-21. PubMed ID: 7937865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
    Brown PM; Debanne MT; Grothe S; Bergsma D; Caron M; Kay C; O'Connor-McCourt MD
    Eur J Biochem; 1994 Oct; 225(1):223-33. PubMed ID: 7925442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-alpha and epidermal growth factor activate mitogen-activated protein kinase and its substrates in intestinal epithelial cells.
    Oliver BL; Sha'afi RI; Hajjar JJ
    Proc Soc Exp Biol Med; 1995 Nov; 210(2):162-70. PubMed ID: 7568287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathways resulting in growth arrest.
    Justman QA; Clinton GM
    J Biol Chem; 2002 Jun; 277(23):20618-24. PubMed ID: 11934884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmembrane signaling by epidermal growth factor receptors lacking autophosphorylation sites.
    Decker SJ
    J Biol Chem; 1993 May; 268(13):9176-9. PubMed ID: 8387484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor contains both positive and negative determinants for interaction with ErbB-2/ErbB-3 heterodimers.
    Stortelers C; van De Poll ML; Lenferink AE; Gadellaa MM; van Zoelen C; van Zoelen EJ
    Biochemistry; 2002 Apr; 41(13):4292-301. PubMed ID: 11914075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenesis reveals a role for epidermal growth factor receptor extracellular subdomain IV in ligand binding.
    Saxon ML; Lee DC
    J Biol Chem; 1999 Oct; 274(40):28356-62. PubMed ID: 10497195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro.
    Morishige K; Kurachi H; Amemiya K; Adachi H; Inoue M; Miyake A; Tanizawa O; Sakoyama Y
    Cancer Res; 1991 Nov; 51(21):5951-5. PubMed ID: 1718591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential binding and biological activities of epidermal growth factor and transforming growth factor alpha in a human pancreatic cancer cell line.
    Korc M; Chandrasekar B; Shah GN
    Cancer Res; 1991 Dec; 51(23 Pt 1):6243-9. PubMed ID: 1933884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the transforming growth factor alpha B-loop beta-sheet to binding and activation of the epidermal growth factor receptor.
    Richter A; Drummond DR; MacGarvie J; Puddicombe SM; Chamberlin SG; Davies DE
    J Biol Chem; 1995 Jan; 270(4):1612-6. PubMed ID: 7829492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-binding transforming growth factor alpha-Pseudomonas exotoxin A. A heparan sulfate-modulated recombinant toxin cytotoxic to cancer cells and proliferating smooth muscle cells.
    Mesri EA; Kreitman RJ; Fu YM; Epstein SE; Pastan I
    J Biol Chem; 1993 Mar; 268(7):4853-62. PubMed ID: 8444864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations within subdomain II of the extracellular region of epidermal growth factor receptor selectively alter TGF alpha binding.
    Harte MT; Gentry LE
    Arch Biochem Biophys; 1995 Oct; 322(2):378-89. PubMed ID: 7574711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family.
    Barnard JA; Graves-Deal R; Pittelkow MR; DuBois R; Cook P; Ramsey GW; Bishop PR; Damstrup L; Coffey RJ
    J Biol Chem; 1994 Sep; 269(36):22817-22. PubMed ID: 8077234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced modulation of keratinocyte motility by transforming growth factor-alpha (TGF-alpha) relative to epidermal growth factor (EGF).
    Cha D; O'Brien P; O'Toole EA; Woodley DT; Hudson LG
    J Invest Dermatol; 1996 Apr; 106(4):590-7. PubMed ID: 8617990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
    Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF
    J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding of HB-EGF to tumour cells is blocked by mAbs which act as EGF and TGF alpha antagonists.
    Modjtahedi H; Dean C
    Biochem Biophys Res Commun; 1995 Feb; 207(1):389-97. PubMed ID: 7857293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters.
    Visser CJ; Bruggink AH; Korc M; Kobrin MS; de Weger RA; Seifert-Bock I; van Blokland WT; van Garderen-Hoetmer A; Woutersen RA
    Carcinogenesis; 1996 Apr; 17(4):779-85. PubMed ID: 8625491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratinocyte growth factor receptor ligands induce transforming growth factor alpha expression and activate the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes.
    Dlugosz AA; Cheng C; Denning MF; Dempsey PJ; Coffey RJ; Yuspa SH
    Cell Growth Differ; 1994 Dec; 5(12):1283-92. PubMed ID: 7535082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain.
    Elleman TC; Domagala T; McKern NM; Nerrie M; Lönnqvist B; Adams TE; Lewis J; Lovrecz GO; Hoyne PA; Richards KM; Howlett GJ; Rothacker J; Jorissen RN; Lou M; Garrett TP; Burgess AW; Nice EC; Ward CW
    Biochemistry; 2001 Jul; 40(30):8930-9. PubMed ID: 11467954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential induction of phosphatidylcholine hydrolysis, diacylglycerol formation and protein kinase C activation by epidermal growth factor and transforming growth factor-alpha in normal human skin fibroblasts and keratinocytes.
    Reynolds NJ; Talwar HS; Baldassare JJ; Henderson PA; Elder JT; Voorhees JJ; Fisher GJ
    Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):535-44. PubMed ID: 7690546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.